Published in Mol Microbiol on December 01, 2003
Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect Immun (2005) 3.44
Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter. J Bacteriol (2004) 3.41
The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr Opin Microbiol (2009) 2.21
Identification of virulence genes linked with diarrhea due to atypical enteropathogenic Escherichia coli by DNA microarray analysis and PCR. J Clin Microbiol (2006) 1.86
Bioinformatics analysis of the locus for enterocyte effacement provides novel insights into type-III secretion. BMC Microbiol (2005) 1.78
Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science (2010) 1.77
Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog (2009) 1.61
Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc Natl Acad Sci U S A (2006) 1.57
Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens. Infect Immun (2005) 1.51
High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One (2013) 1.50
Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med (2006) 1.38
Strategies for Intracellular Survival of Burkholderia pseudomallei. Front Microbiol (2011) 1.35
SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect Immun (2005) 1.32
EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics. Infect Immun (2005) 1.32
A bacterial type III effector family uses the papain-like hydrolytic activity to arrest the host cell cycle. Proc Natl Acad Sci U S A (2009) 1.29
Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens. Infect Immun (2005) 1.29
Comparative genomic analysis using microarray demonstrates a strong correlation between the presence of the 80-kilobase pathogenicity island and pathogenicity in Kanagawa phenomenon-positive Vibrio parahaemolyticus strains. Infect Immun (2008) 1.26
Genetic analysis of enteropathogenic and enterohemorrhagic Escherichia coli serogroup O103 strains by molecular typing of virulence and housekeeping genes and pulsed-field gel electrophoresis. J Clin Microbiol (2005) 1.25
Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog (2010) 1.23
Structure of the cyclomodulin Cif from pathogenic Escherichia coli. J Mol Biol (2008) 1.16
The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis (2011) 1.15
Functional analysis of VopF activity required for colonization in Vibrio cholerae. MBio (2010) 1.14
Rapid microarray-based genotyping of enterohemorrhagic Escherichia coli serotype O156:H25/H-/Hnt isolates from cattle and clonal relationship analysis. Appl Environ Microbiol (2010) 1.14
The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Cell Microbiol (2009) 1.14
Systematic identification and sequence analysis of the genomic islands of the enteropathogenic Escherichia coli strain B171-8 by the combined use of whole-genome PCR scanning and fosmid mapping. J Bacteriol (2008) 1.11
Polarity of enteropathogenic Escherichia coli EspA filament assembly and protein secretion. J Bacteriol (2005) 1.09
Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS One (2009) 1.08
Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli. J Bacteriol (2007) 1.06
The Shiga toxin 1-converting bacteriophage BP-4795 encodes an NleA-like type III effector protein. J Bacteriol (2005) 1.06
Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun (2008) 1.02
Comparative analysis of the locus of enterocyte effacement and its flanking regions. Infect Immun (2009) 1.02
A bacterial cytotoxin identifies the RhoA exchange factor Net1 as a key effector in the response to DNA damage. PLoS One (2008) 1.00
Crystal structures of Cif from bacterial pathogens Photorhabdus luminescens and Burkholderia pseudomallei. PLoS One (2009) 0.98
Molecular analysis of virulence profiles and Shiga toxin genes in food-borne Shiga toxin-producing Escherichia coli. Appl Environ Microbiol (2009) 0.98
Efficient translocation of EspC into epithelial cells depends on enteropathogenic Escherichia coli and host cell contact. Infect Immun (2006) 0.98
The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells. Infect Immun (2009) 0.95
EspC promotes epithelial cell detachment by enteropathogenic Escherichia coli via sequential cleavages of a cytoskeletal protein and then focal adhesion proteins. Infect Immun (2014) 0.91
Molecular characterization and distribution of genes encoding members of the type III effector nleA family among pathogenic Escherichia coli strains. J Clin Microbiol (2007) 0.91
Characterization of the NleF effector protein from attaching and effacing bacterial pathogens. FEMS Microbiol Lett (2008) 0.91
Cyclomodulins in urosepsis strains of Escherichia coli. J Clin Microbiol (2010) 0.90
Cell cycle arrest induced by the bacterial adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Cell Microbiol (2010) 0.89
Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J Gastroenterol (2010) 0.88
Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system. J Inflamm (Lond) (2011) 0.86
The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-delivered Tir effector. Cell Microbiol (2010) 0.86
Enteric pathogens deploy cell cycle inhibiting factors to block the bactericidal activity of Perforin-2. Elife (2015) 0.86
The molecular basis of ubiquitin-like protein NEDD8 deamidation by the bacterial effector protein Cif. Proc Natl Acad Sci U S A (2012) 0.86
Cycle inhibiting factors (cifs): cyclomodulins that usurp the ubiquitin-dependent degradation pathway of host cells. Toxins (Basel) (2011) 0.86
Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes. Biomed Res Int (2012) 0.85
Escherichia coli cytotoxic necrotizing factor 1 blocks cell cycle G2/M transition in uroepithelial cells. Infect Immun (2006) 0.84
Pathogenic Bacterial Proteins and their Anti-Inflammatory Effects in the Eukaryotic Host. Antiinflamm Antiallergy Agents Med Chem (2009) 0.82
Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells. Infect Immun (2010) 0.82
What a difference a Dalton makes: bacterial virulence factors modulate eukaryotic host cell signaling systems via deamidation. Microbiol Mol Biol Rev (2013) 0.82
Cytotoxic Escherichia coli strains encoding colibactin colonize laboratory mice. Microbes Infect (2016) 0.82
Expression and regulation of the Escherichia coli O157:H7 effector proteins NleH1 and NleH2. PLoS One (2012) 0.81
The cyclomodulin cycle inhibiting factor (CIF) alters cullin neddylation dynamics. J Biol Chem (2013) 0.81
Regulation of nleA in Shiga toxin-producing Escherichia coli O84:H4 strain 4795/97. J Bacteriol (2010) 0.81
Molecular risk assessment and epidemiological typing of Shiga toxin-producing Escherichia coli by using a novel PCR binary typing system. Appl Environ Microbiol (2011) 0.80
Quantitative proteomic analysis of Burkholderia pseudomallei Bsa type III secretion system effectors using hypersecreting mutants. Mol Cell Proteomics (2015) 0.79
Reduced set of virulence genes allows high accuracy prediction of bacterial pathogenicity in humans. PLoS One (2012) 0.79
A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli. J Bacteriol (2012) 0.79
The ubiquitin system: a critical regulator of innate immunity and pathogen-host interactions. Cell Mol Immunol (2016) 0.79
Analysis of the prevalence, secretion and function of a cell cycle-inhibiting factor in the melioidosis pathogen Burkholderia pseudomallei. PLoS One (2014) 0.78
Rifaximin-mediated changes to the epithelial cell proteome: 2-D gel analysis. PLoS One (2013) 0.77
Distribution of non-LEE-encoded type 3 secretion system dependent effectors in enteropathogenic Escherichia coli. Braz J Microbiol (2014) 0.76
Disease and Carrier Isolates of Neisseria meningitidis Cause G1 Cell Cycle Arrest in Human Epithelial Cells. Infect Immun (2016) 0.75
Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science (2006) 4.58
Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter. J Bacteriol (2004) 3.41
Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res (2005) 3.22
A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J Immunol (2010) 3.20
Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A (2010) 3.18
TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell Microbiol (2004) 2.91
Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob Agents Chemother (2004) 2.15
Identification of an Escherichia coli operon required for formation of the O-antigen capsule. J Bacteriol (2005) 2.14
EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol (2003) 2.04
Small RNAs encoded within genetic islands of Salmonella typhimurium show host-induced expression and role in virulence. Nucleic Acids Res (2008) 2.04
Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection. Infect Immun (2004) 1.95
Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun (2009) 1.93
The crystal structure of Escherichia coli group 4 capsule protein GfcC reveals a domain organization resembling that of Wza. Biochemistry (2011) 1.93
Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun (2003) 1.90
Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B. Infect Immun (2002) 1.89
Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol (2005) 1.87
Performances of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for rapid identification of bacteria in routine clinical microbiology. J Clin Microbiol (2012) 1.84
The type III secretion effector NleE inhibits NF-kappaB activation. PLoS Pathog (2010) 1.79
Phylogenetic distribution of virulence-associated genes among Escherichia coli isolates associated with neonatal bacterial meningitis in the Netherlands. J Infect Dis (2002) 1.77
Identification and molecular characterization of an N-acetylmuramyl-L-alanine amidase Sle1 involved in cell separation of Staphylococcus aureus. Mol Microbiol (2005) 1.72
Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli. Cell Host Microbe (2008) 1.71
Host proteasomal degradation generates amino acids essential for intracellular bacterial growth. Science (2011) 1.69
Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol (2005) 1.66
Thermoregulated expression of virulence genes in enteropathogenic Escherichia coli. Microbiology (2002) 1.64
Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. J Clin Invest (2002) 1.64
Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J Clin Microbiol (2008) 1.63
Bacterial toxins that modulate host cell-cycle progression. Curr Opin Microbiol (2005) 1.62
Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. J Infect Dis (2007) 1.61
Common virulence factors and genetic relationships between O18:K1:H7 Escherichia coli isolates of human and avian origin. J Clin Microbiol (2006) 1.59
Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima. J Antimicrob Chemother (2009) 1.56
Metalloprotease type III effectors that specifically cleave JNK and NF-κB. EMBO J (2010) 1.55
Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (Type IV). J Clin Microbiol (2003) 1.54
Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother (2005) 1.50
Surgical hand antisepsis in veterinary practice: evaluation of soap scrubs and alcohol based rub techniques. Vet J (2011) 1.48
Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges. J Biol Chem (2005) 1.48
The gate controlling cell wall synthesis in Staphylococcus aureus. Mol Microbiol (2004) 1.47
A mosaic pathogenicity island made up of the locus of enterocyte effacement and a pathogenicity island of Escherichia coli O157:H7 is frequently present in attaching and effacing E. coli. Infect Immun (2003) 1.43
Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6. Diagn Microbiol Infect Dis (2011) 1.43
Identification of clinical Streptococcus pneumoniae isolates among other alpha and nonhemolytic streptococci by use of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system. J Clin Microbiol (2013) 1.40
Characterization of the novel factor paa involved in the early steps of the adhesion mechanism of attaching and effacing Escherichia coli. Infect Immun (2003) 1.40
Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci (2007) 1.37
Extensive genomic diversity and selective conservation of virulence-determinants in enterohemorrhagic Escherichia coli strains of O157 and non-O157 serotypes. Genome Biol (2007) 1.37
Molecular characterization of an atl null mutant of Staphylococcus aureus. Microbiol Immunol (2002) 1.35
E. coli transports aggregated proteins to the poles by a specific and energy-dependent process. J Mol Biol (2009) 1.34
Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis. Int J Microbiol (2011) 1.33
Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol Lett (2007) 1.32
Staphylococcus aureus MazF specifically cleaves a pentad sequence, UACAU, which is unusually abundant in the mRNA for pathogenic adhesive factor SraP. J Bacteriol (2009) 1.31
Beta-hydroxybutyrate abrogates formation of bovine neutrophil extracellular traps and bactericidal activity against mammary pathogenic Escherichia coli. Infect Immun (2008) 1.27
Transduction of porcine enteropathogenic Escherichia coli with a derivative of a shiga toxin 2-encoding bacteriophage in a porcine ligated ileal loop system. Appl Environ Microbiol (2003) 1.26
Genetic analysis of enteropathogenic and enterohemorrhagic Escherichia coli serogroup O103 strains by molecular typing of virulence and housekeeping genes and pulsed-field gel electrophoresis. J Clin Microbiol (2005) 1.25
Pathogenic bacteria target NEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog (2010) 1.23
Outer membrane protein 100, a versatile virulence factor of Actinobacillus actinomycetemcomitans. Mol Microbiol (2003) 1.23
Animal and human pathogenic Escherichia coli strains share common genetic backgrounds. Infect Genet Evol (2011) 1.23
Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J Infect Dis (2002) 1.20
Presence in bovine enteropathogenic (EPEC) and enterohaemorrhagic (EHEC) Escherichia coli of genes encoding for putative adhesins of human EHEC strains. Res Microbiol (2002) 1.19
Meropenem resistance in imipenem-susceptible meropenem-resistant Klebsiella pneumoniae isolates not detected by rapid automated testing systems. J Clin Microbiol (2013) 1.19
Ler is a negative autoregulator of the LEE1 operon in enteropathogenic Escherichia coli. J Bacteriol (2005) 1.19
Bacterial cyclomodulin Cif blocks the host cell cycle by stabilizing the cyclin-dependent kinase inhibitors p21 and p27. Cell Microbiol (2008) 1.18
Escherichia coli cyclomodulin Cif induces G2 arrest of the host cell cycle without activation of the DNA-damage checkpoint-signalling pathway. Cell Microbiol (2006) 1.18
Integration host factor (IHF) mediates repression of flagella in enteropathogenic and enterohaemorrhagic Escherichia coli. Microbiology (2003) 1.16
Structure of the cyclomodulin Cif from pathogenic Escherichia coli. J Mol Biol (2008) 1.16
Escherichia coli strains with the capacity for long-term persistence in the bowel microbiota carry the potentially genotoxic pks island. Microb Pathog (2012) 1.14
An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J Biol Chem (2003) 1.14
Staphylococcal exfoliative toxin B specifically cleaves desmoglein 1. J Invest Dermatol (2002) 1.13
Intimate host attachment: enteropathogenic and enterohaemorrhagic Escherichia coli. Cell Microbiol (2013) 1.12
Concert of regulators to switch on LEE expression in enterohemorrhagic Escherichia coli O157:H7: interplay between Ler, GrlA, HNS and RpoS. Int J Med Microbiol (2006) 1.12
Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. J Antimicrob Chemother (2008) 1.11
Clinical manifestations of staphylococcal scalded-skin syndrome depend on serotypes of exfoliative toxins. J Clin Microbiol (2005) 1.11
HEp-2 cell adherence, actin aggregation, and intimin types of attaching and effacing Escherichia coli strains isolated from healthy infants in Germany and Australia. Infect Immun (2003) 1.10
Increased glycan chain length distribution and decreased susceptibility to moenomycin in a vancomycin-resistant Staphylococcus aureus mutant. Antimicrob Agents Chemother (2002) 1.10
Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes (2012) 1.09
Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS One (2009) 1.08
Genetically engineered enteropathogenic Escherichia coli strain elicits a specific immune response and protects against a virulent challenge. Microbes Infect (2003) 1.07
ClbP is a prototype of a peptidase subgroup involved in biosynthesis of nonribosomal peptides. J Biol Chem (2011) 1.07
Imaging the assembly, structure and activity of type III secretion systems. Cell Microbiol (2009) 1.07
Mammary pathogenic Escherichia coli. Curr Opin Microbiol (2008) 1.06
Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli. J Bacteriol (2007) 1.06
CesAB is an enteropathogenic Escherichia coli chaperone for the type-III translocator proteins EspA and EspB. Microbiology (2003) 1.05
Identification of six major outer membrane proteins from Actinobacillus actinomycetemcomitans. Gene (2002) 1.05
A Salmonella enterica serovar typhimurium hemA mutant is highly susceptible to oxidative DNA damage. J Bacteriol (2002) 1.04
Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria. J Clin Microbiol (2003) 1.03